// modify the 7 lines below
$alt_texts= array ('Benign prostatic hyperplasia, or BPH for short, is the enlargement of the prostate gland. It is caused by excess growth of cells in the prostate. This condition is not the same as prostate cancer','Alternate Names : Dysmenorrhea. Menstrual cramps are the pain and cramping some women experience during their monthly periods. The term dysmenorrhea usually refers to pain and cramps severe enough to prevent normal activity','An ectopic pregnancy occurs when a fertilized egg implants outside of the uterus. The most common site is within a fallopian tube. More rarely an embryo may implant within an ovary, in the cervix, or on the abdominal wall','Pregnancy is the period from conception to birth. A pregnancy may be complicated by health problems or lifestyle issues known as risk factors. These risk factors can affect the mother or fetus, or both','Topiramate (toe-PYRE-a-mate) is used to help control some types of seizures in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to help control seizures for as long as you continue to take it.','Irritable bowel syndrome, or IBS, is a condition characterized by abdominal cramping, bloating, gas, and other changes in the bowels','Depression is a medical condition that leads to intense feelings of sadness or despair. These feelings don\'t go away on their own. They are not necessarily related to a particular life event','Tacrolimus ( ta-KROE-li-mus) ointment is used for moderate to severe atopic dermatitis. This is a skin condition where there is itching, redness and inflammation, much like an allergic reaction','Type 2 diabetes mellitus, more often known as type 2 diabetes, is the most common type of diabetes','Personality disorders are chronic mental disorders','Presbyopia is an eye condition in which the lens loses the ability to focus over time');
$links= array('http://www.3-rx.com/benign-prostatic-hyperplasia/default.php','http://www.3-rx.com/menstrual-cramps/default.php','http://www.3-rx.com/ectopic-pregnancy/default.php','http://www.3-rx.com/pregnancy-risk-factors/default.php','http://www.3-rx.com/drugs/detailed/topiramate/default.php','http://www.3-rx.com/irritable-bowel-syndrome/default.php','http://www.3-rx.com/depression.php','http://www.3-rx.com/drugs/detailed/tacrolimus-systemic/before-using.php','http://www.3-rx.com/diabetes.php','http://www.3-rx.com/personality-disorders/default.php','http://www.3-rx.com/presbyopia/default.php'); /* e.g. 'http://www.yoursite.com' */
// YOU DO NOT NEED TO MODIFY BELOW
mt_srand ((double) microtime () * 1000000);
Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the ACS journal Industrial & Engineering Chemistry Research the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Type 1 diabetes, previously known as juvenile diabetes, affects about 1.25 million Americans. About 200,000 of them are under 20 years old. The condition arises when a person’s own immune system destroys the pancreas cells that make insulin, the hormone that converts blood sugar into energy. To make up for this loss of insulin production, patients must take insulin daily. Current delivery methods involve multiple daily injections or insulin pump therapy, both requiring the user to actively track glucose and calculate the needed insulin dose. There is also a significant time lag between when a dose is needed and when it can take effect. Francis J. Doyle III and colleagues wanted to find a way to make monitoring and insulin delivery automatic and needle-free.
The researchers designed an algorithm that monitors blood sugar levels and computes an insulin dose that it delivers quickly and automatically when necessary.
The algorithm is designed to work with implanted devices, specifically with an artificial pancreas, and would overcome the delays experienced with current devices. Computer testing of the algorithm simulated the rise and fall of glucose that would correspond to meals and an overnight period of sleep. The artificial pancreas maintained blood glucose within the target range nearly 80 percent of the time. The researchers say they will soon test the device in animals.
The authors acknowledge funding from the National Science Foundation and the National Institutes of Health.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.